Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Oakwood's Leuprolide Acetate 22.5 mg in Prostate Cancer
NCT00598312Phase 3Completed
- Sponsor
- Oakwood Laboratories
- Start
- Apr 2007
- Primary completion
- Aug 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in prostate cancer (PCa), sponsored by Oakwood Laboratories. Started Apr 2007; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00598312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598312.